Angiotensin type 2 receptors are reexpressed by cardiac fibroblasts from failing myopathic hamster hearts and inhibit cell growth and fibrillar collagen metabolism. 1997

N Ohkubo, and H Matsubara, and Y Nozawa, and Y Mori, and S Murasawa, and K Kijima, and K Maruyama, and H Masaki, and Y Tsutumi, and Y Shibazaki, and T Iwasaka, and M Inada
Department of Medicine II, Kansai Medical University, Moriguchi, Osaka, Japan.

BACKGROUND Angiotensin (Ang) II type 1 receptor (AT1-R) induces cardiomyocyte hypertrophy and fibroblast proliferation, whereas the physiological role of AT2-R in cardiac remodeling remains poorly defined. RESULTS Using Bio14.6 cardiomyopathic (CM) hamsters, we found that AT2-R sites were increased by 153% during heart failure compared with F1B controls. AT1-R numbers were increased by 72% in the hypertrophy stage and then decreased to the control level during heart failure. Such differential regulation of AT2-R and AT1-R during heart failure was consistent with changes in the respective mRNA levels. Autoradiography and immunocytochemistry revealed that both AT2-R and AT1-R are localized at higher densities in fibroblasts present in fibrous regions. Surrounding myocardium predominantly expressed AT1-R, but the level of expression was less than that in fibrous regions. Cardiac fibroblasts isolated from CM hearts during heart failure but not from control hamsters expressed AT2-R (30 fmol/mg protein). Using the cardiac fibroblasts expressing AT2-R, we found that Ang II stimulated net collagenous protein production by 48% and pretreatment with an AT2-R antagonist, PD123319, evoked a further elevation (83%). Ang II-induced synthesis of fibronectin and collagen type I were enhanced by 40% and 53%, respectively, by pretreatment with PD123319. Ang II-induced DNA synthesis (assessed by [3H]thymidine uptake) was significantly increased by PD123319, and the AT2-R agonist CGP42112A reduced the serum-stimulated increase in cell numbers by 23%. Treatment with an AT1-R antagonist, TCV116, for 20 weeks inhibited progression of interstitial fibrosis by 28%, whereas with 44-week PD123319 treatment but not 20-week treatment, the extent of the fibrous region was increased significantly, by 29%. CONCLUSIONS These findings demonstrate that AT2-R is re-expressed by cardiac fibroblasts present in fibrous regions in failing CM hearts and that the increased AT2-R exerts an anti-AT1-R action on the progression of interstitial fibrosis during cardiac remodeling by inhibiting both fibrillar collagen metabolism and growth of cardiac fibroblasts.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D009210 Myofibrils The long cylindrical contractile organelles of STRIATED MUSCLE cells composed of ACTIN FILAMENTS; MYOSIN filaments; and other proteins organized in arrays of repeating units called SARCOMERES . Myofilaments,Myofibril,Myofilament
D009929 Organ Size The measurement of an organ in volume, mass, or heaviness. Organ Volume,Organ Weight,Size, Organ,Weight, Organ
D011233 Precipitin Tests Serologic tests in which a positive reaction manifested by visible CHEMICAL PRECIPITATION occurs when a soluble ANTIGEN reacts with its precipitins, i.e., ANTIBODIES that can form a precipitate. Precipitin Test,Test, Precipitin,Tests, Precipitin
D011945 Receptors, Angiotensin Cell surface proteins that bind ANGIOTENSINS and trigger intracellular changes influencing the behavior of cells. Angiotensin Receptor,Angiotensin Receptors,Angiotensin II Receptor,Angiotensin III Receptor,Receptor, Angiotensin II,Receptor, Angiotensin III,Receptor, Angiotensin
D002311 Cardiomyopathy, Dilated A form of CARDIAC MUSCLE disease that is characterized by ventricular dilation, VENTRICULAR DYSFUNCTION, and HEART FAILURE. Risk factors include SMOKING; ALCOHOL DRINKING; HYPERTENSION; INFECTION; PREGNANCY; and mutations in the LMNA gene encoding LAMIN TYPE A, a NUCLEAR LAMINA protein. Cardiomyopathy, Congestive,Congestive Cardiomyopathy,Dilated Cardiomyopathy,Cardiomyopathy, Dilated, 1a,Cardiomyopathy, Dilated, Autosomal Recessive,Cardiomyopathy, Dilated, CMD1A,Cardiomyopathy, Dilated, LMNA,Cardiomyopathy, Dilated, With Conduction Defect 1,Cardiomyopathy, Dilated, with Conduction Deffect1,Cardiomyopathy, Familial Idiopathic,Cardiomyopathy, Idiopathic Dilated,Cardiomyopathies, Congestive,Cardiomyopathies, Dilated,Cardiomyopathies, Familial Idiopathic,Cardiomyopathies, Idiopathic Dilated,Congestive Cardiomyopathies,Dilated Cardiomyopathies,Dilated Cardiomyopathies, Idiopathic,Dilated Cardiomyopathy, Idiopathic,Familial Idiopathic Cardiomyopathies,Familial Idiopathic Cardiomyopathy,Idiopathic Cardiomyopathies, Familial,Idiopathic Cardiomyopathy, Familial,Idiopathic Dilated Cardiomyopathies,Idiopathic Dilated Cardiomyopathy
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D003094 Collagen A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). Avicon,Avitene,Collagen Felt,Collagen Fleece,Collagenfleece,Collastat,Dermodress,Microfibril Collagen Hemostat,Pangen,Zyderm,alpha-Collagen,Collagen Hemostat, Microfibril,alpha Collagen
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast

Related Publications

N Ohkubo, and H Matsubara, and Y Nozawa, and Y Mori, and S Murasawa, and K Kijima, and K Maruyama, and H Masaki, and Y Tsutumi, and Y Shibazaki, and T Iwasaka, and M Inada
September 2008, European journal of heart failure,
N Ohkubo, and H Matsubara, and Y Nozawa, and Y Mori, and S Murasawa, and K Kijima, and K Maruyama, and H Masaki, and Y Tsutumi, and Y Shibazaki, and T Iwasaka, and M Inada
July 1989, The Journal of clinical endocrinology and metabolism,
N Ohkubo, and H Matsubara, and Y Nozawa, and Y Mori, and S Murasawa, and K Kijima, and K Maruyama, and H Masaki, and Y Tsutumi, and Y Shibazaki, and T Iwasaka, and M Inada
July 2005, Current opinion in cardiology,
N Ohkubo, and H Matsubara, and Y Nozawa, and Y Mori, and S Murasawa, and K Kijima, and K Maruyama, and H Masaki, and Y Tsutumi, and Y Shibazaki, and T Iwasaka, and M Inada
October 2002, Nihon rinsho. Japanese journal of clinical medicine,
N Ohkubo, and H Matsubara, and Y Nozawa, and Y Mori, and S Murasawa, and K Kijima, and K Maruyama, and H Masaki, and Y Tsutumi, and Y Shibazaki, and T Iwasaka, and M Inada
May 2008, The Prostate,
N Ohkubo, and H Matsubara, and Y Nozawa, and Y Mori, and S Murasawa, and K Kijima, and K Maruyama, and H Masaki, and Y Tsutumi, and Y Shibazaki, and T Iwasaka, and M Inada
December 1977, Journal of applied physiology: respiratory, environmental and exercise physiology,
N Ohkubo, and H Matsubara, and Y Nozawa, and Y Mori, and S Murasawa, and K Kijima, and K Maruyama, and H Masaki, and Y Tsutumi, and Y Shibazaki, and T Iwasaka, and M Inada
April 2017, Journal of the American Heart Association,
N Ohkubo, and H Matsubara, and Y Nozawa, and Y Mori, and S Murasawa, and K Kijima, and K Maruyama, and H Masaki, and Y Tsutumi, and Y Shibazaki, and T Iwasaka, and M Inada
April 1999, Methods and findings in experimental and clinical pharmacology,
N Ohkubo, and H Matsubara, and Y Nozawa, and Y Mori, and S Murasawa, and K Kijima, and K Maruyama, and H Masaki, and Y Tsutumi, and Y Shibazaki, and T Iwasaka, and M Inada
August 2011, Microscopy and microanalysis : the official journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada,
N Ohkubo, and H Matsubara, and Y Nozawa, and Y Mori, and S Murasawa, and K Kijima, and K Maruyama, and H Masaki, and Y Tsutumi, and Y Shibazaki, and T Iwasaka, and M Inada
July 1994, Journal of molecular and cellular cardiology,
Copied contents to your clipboard!